At the Tandem Meetings 2025, researchers presented a study of scalp cooling in patients undergoing chemotherapy and ASCT.

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient ...

Adam Perry shares the story of his journey discussing his diagnosis, treatment and the importance of early detection.

While we've known that a healthy diet reduces the overall chance of getting cancer, there's now evidence that one eating plan ...

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

Triplet therapy with bortezomib, lenalidomide and dexamethasone — a regimen often referred to as VRd — is a current standard ...

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

Pharmaceutical Administration Bureau has approved IASO Biotherapeutics’ new drug application (NDA) for equecabtagene ...